Human Embryonic Stem Cell (hESC) Research

World Market Report

MCP-6831

EXECUTIVE ENGAGEMENTS

POOL

1802
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

324
Interactions with Platform & by Email

PARTICIPANTS

72
Unique # Participated

VALIDATIONS

16
Responses Validated*

COMPANIES

24
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2023

TABLES

122

PAGES

184

EDITION

15

PRICE

USD 5450

CODE

MCP-6831


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
»Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
»Online interactive peer-to-peer collaborative bespoke updates
»Access to our digital archives and MarketGlass Research Platform
»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Human Embryonic Stem Cell (hESC) Research Market to Reach $1.3 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Human Embryonic Stem Cell (hESC) Research estimated at US$2.5 Billion in the year 2022, is projected to reach a revised size of US$1.3 Billion by 2030, growing at a CAGR of -8% over the analysis period 2022-2030. Regenerative Medicine, one of the segments analyzed in the report, is projected to record a -8% CAGR and reach US$892.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Stem Cell Biology Research segment is readjusted to a revised -7.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $732.7 Million, While China is Forecast to Grow at -8.4% CAGR
The Human Embryonic Stem Cell (hESC) Research market in the U.S. is estimated at US$732.7 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$219.3 Million by the year 2030 trailing a CAGR of -8.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -8.5% and -8.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately -9.1% CAGR.

SELECT PLAYERS

Astellas Institute of Regenerative Medicine; Asterias Biotherapeutics, Inc.; BD Biosciences; Cell Cure Neurosciences Ltd.; Cellular Dynamics International; GE Healthcare; PerkinElmer, Inc.; Reliance Life Sciences Ltd.; Research & Diagnostics Systems, Inc.; STEMCELL Technologies, Inc.; Stemina Biomarker Discovery, Inc.; Takara Bio, Inc.; TATAA Biocenter AB; Thermo Fischer Scientific Inc.; UK Stem Cell Bank; ViaCyte, Inc.

SEGMENTS

» Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Stem Cells Research: A Sunrise Sector in Biotechnology Arena
Human Embryonic Stem Cells - An Introduction
Embryonic Stem Cells - Sources and Cell Culture
Comparison on Adult and Embryonic Stem Cells
Advantages and Drawbacks of Various Stem Cells
Recent Market Activity
Human Embryonic Stem Cells - The Market Perspective
Timeline for Embryonic Stem Cell Research Activities: Major Events from 1963 through 2014
Teratomas - No Longer an Impediment to Stem Cell Therapy Development
Human Embryonic and Induced Pluripotent Stem Cell Research Trends
Human Embryonic Stem Cell Research: Key Statistical Highlights
Research Topics on hESC and hiPSC by Number of Papers Published: 2011-2013
Haploid Human Embryonic Stem Cell Line: The New Frontier
Human Induced Pluripotent Stem Cells Remains Best Alternative for hESC
Human Embryonic Stem Cell (hESC) Research – Global Key Competitors Percentage Market Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
Astellas Institute of Regenerative Medicine (US)
Asterias Biotherapeutics, Inc. (US)
BD Biosciences (US)
Cell Cure Neurosciences Ltd. (Israel)
Cellular Dynamics International (US)
GE Healthcare (UK)
MilliporeSigma (US)
PerkinElmer, Inc. (US)
Reliance Life Sciences Ltd. (India)
Research & Diagnostics Systems, Inc. (US)
SABiosciences Corp. (US)
STEMCELL Technologies, Inc. (Canada)
Stemina Biomarker Discovery, Inc. (US)
Takara Bio, Inc. (Japan)
TATAA Biocenter AB (Sweden)
Thermo Fisher Scientific, Inc. (US)
UK Stem Cell Bank (UK)
ViaCyte, Inc. (US)
Vitrolife AB (Sweden)
3. MARKET TRENDS & DRIVERS
Issues Hindering Development of hESC Research
Consideration of Best Translational Pathways Pivotal in Ensuring Growth Of hESCs
Ethical Issues and Technical Hurdles Bog Down hESC Research
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2021 & 2027
World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Recent Past, Current & Future Analysis for Stem Cell Biology Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Stem Cell Biology Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Recent Past, Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Recent Past, Current & Future Analysis for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Human Embryonic Stem Cell (hESC) Research Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
UNITED STATES
Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2021 & 2027
JAPAN
Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2021 & 2027
CHINA
Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2021 & 2027
EUROPE
Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2021 & 2027
Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2021 & 2027
FRANCE
Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2021 & 2027
GERMANY
Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2021 & 2027
UNITED KINGDOM
Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2021 & 2027
ASIA-PACIFIC
Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2021 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com